Document is current

Article History

Received: 13 July 2018

Accepted: 26 December 2018

First Online: 5 January 2019

Ethics approval and consent to participate

: The University of Alabama at Birmingham’s Institutional Review Board approved this study and all investigations were conducted in conformity with ethical principles of research. The IRB waived the need for informed consent for this study.

: No individual person’s data were presented in any form in this study and therefore no consent to publish is required.

: JAS has received consultant fees from Crealta/Horizon, UBM LLC, Medscape, WebMD, the National Institutes of Health and the American College of Rheumatology. JAS served as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, Inc., a 501 (c)(3) entity. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS served as a member of the American College of Rheumatology’s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee. DC has no conflicts to declare. There are no non-financial competing interests for any of the authors.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.